Skip to main content
. 2019 Jan 24;30(1):79–87. doi: 10.1089/hum.2018.098

Figure 1.

Figure 1.

Seroprevalence of immunoglobulin (Ig)G and neutralizing antibodies (Nab) against adeno-associated virus (AAV)-LK03, 3B, and 8 in humans. (A) Anti-IgG and Nab seroprevalences against AAV-LK03; (B) anti-IgG titers against AAV-LK03; (C) Nab seroprevalence against AAV-LK03 according to age; (D) Nab titers against AAV-LK03 according to age; (E) comparison of Nab seroprevalence against AAV-LK03, 3B, and 8; (F) comparison of Nab titers against AAV-LK03, 3B, and 8; (G) Nab seroprevalence according to sex; (H) cross-reactivity of Nab between serotypes. Vertical bars represent the mean. Box-and-whisker plots represent the minimum, the mean, the maximum, and the 25th and 75th percentiles. Samples: (A, B) IgG seroprevalence against AAV-LK03, n = 189; (C–F) Nab seroprevalence against AAV-LK03, n = 323; (E, F) against AAV3B and AAV8, n = 129; (G) male and female samples, n = 50 and n = 77, respectively; (H) n = 49.